Medical Assistance

ORS 414.701
Commission may not rely solely on comparative effectiveness research

The Health Evidence Review Commission, in ranking health services or developing guidelines under ORS 414.690 (Prioritized list of health services) or in assessing medical technologies under ORS 414.698 (Comparative effectiveness of medical technologies), and the Pharmacy and Therapeutics Committee, in considering a recommendation for a drug to be included on any preferred drug list or on the Practitioner-Managed Prescription Drug Plan, may not rely solely on the results of comparative effectiveness research. [2011 c.720 §26a]
Note: See note under 414.695 (Medical technology assessment).


Last accessed
Jun. 26, 2021